Compare Cassava Sciences Inc (FLNA) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs 10X Genomics Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while 10X Genomics Inc trades at $59 (market cap $7.61B). The key difference: 10X Genomics Inc is far larger — about 159.4× Cassava Sciences Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | TXG | |
|---|---|---|
Market Cap | $47.75M | $7.61B |
Sector | Health | Health |
52-Week High | $4.64 | $58.57 |
52-Week Low | $0.87 | $11.34 |
Enterprise Value | -$34.93M | $7.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
